Article Details

Corbus in licensing deal for monoclonal antibodies to tackle cancer and fibrotic diseases

Retrieved on: 2021-06-01 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Corbus in licensing deal for monoclonal antibodies to tackle cancer and fibrotic diseases. View article details on hiswai:

Excerpt

... through licensing deals with the University of California San Francisco and Panorama Research Inc for two new monoclonal antibodies (mAbs).

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up